Antibodies against capsular polysaccharides are important in the defense against many pathogenic bacteria. To determine the mechanism for the variability in responses to polysaccharides, a panel of well characterized serologic reagents that identify diagnostic primary amino acid sequences in the framework and hypervariable regions of heavy (H) and light (L) chains were created to characterize the variable region diversity in circulating human antibodies. 10 normal adult volunteers were immunized with the type b capsular polysaccharide of Haemophilus influenzae (Hib PS). By immunoblot analyses each individual was found to use at least three different variable L (VL) families, but all had preferential usage of VH3-derived H chains. Four individuals had lesser populations of VH1-derived H chains and three had populations of VH4-derived H chains, but anti-Hib PS antibodies derived from the VH2, VH5, and VH6 families were not detected. The anti-Hib PS antibodies from all subjects were also identified by serologic markers for two specific types of VH3 H chains. These H chains are structurally related to the 20P1 and 30P1 VH genes that are preferentially rearranged in the early human repertoire. These findings document the VH restriction of physiologic responses to Hib PS immunization, and demonstrate a technique to directly assess the structural and genetic diversity of specific serum antibodies. (J. Clin. Invest. 1991. 88:911-920.)
However, many individuals are unable to mount adequate responses to PS antigens and are at increased risk for these infections. To determine the mechanisms for nonresponsiveness to these antigens, the structural and genetic basis of anti-PS antibody production must be determined.
Haemophilus influenzae type b (Hib) is a leading cause of meningitis in infants, and it is also responsible for other forms of invasive disease (2) . In most populations the peak incidence of Hib meningitis and bacteremia is between 6 and 15 months of age. Susceptibility correlates with a period of anergy to Hib PS and low or absent circulating levels ofprotective antibodies (3) . Also, certain ethnic groups, such as Native Americans, are at high risk of infection with Hib, and they appear to be unable to produce adequate levels of protective antibodies (3) (4) (5) .
The immune response to immunization with the Hib PS has been extensively studied. Isoelectric focusing (IEF) studies have documented the restricted heterogeneity of human antibodies induced by Hib PS, and Insel et al. have reported that most individuals have only one to three distinct antibody spectrotypes that were each presumed to be clonally derived (6, 7) . A cross-reactive idiotype (CR1) has been found on anti-Hib PS antibodies, which has suggested that these antibodies share variable (V) region structural features (8, 9 ). Scott and co-workers recently provided the first sequence data on human antibodies to a bacterial PS. They reported partial protein sequences of V regions from circulating IgG anti-Hib PS antibodies that were purified to monoclonality. The heavy (H) chains were derived from a single, large VH family, while light (L) chains from at least four VL gene families were found in different individuals (10) . Subsequently, the anti-Hib PS antibodies from four selected individuals were shown to have L chains with protein sequences that are characteristic of the germline VK2 gene, A2 (1 1).
To survey the genetic and structural V region diversity of specifically induced human circulating antibodies, we have developed a technique of serologic characterization that employs antipeptide antibodies that are specific for sequence motifs that are characteristic ofV region gene families, and subsets offamilies. In this report we have directly analyzed the circulating anti-Hib PS antibodies from 10 normal adult volunteers. These antibodies were precipitated with Hib PS, and the H and L chains from these precipitates were electrophoretically separated. Immunoblots were then probed with a panel of well characterized serologic reagents that identify diagnostic primary amino acid sequences in the framework (FR) and hypervariable (HV) regions of H and L chains (12) (13) (14) . By this independent method, we confirmed earlier findings that induced anti-Hib PS antibodies employ L chains from several VL families. In contrast, the H chains ofthese antibodies were found to have restricted VH region heterogeneity. The anti-Hib PS anti-bodies were shown to preferentially use VH3 H chains. Reagents specific for four types ofVH3 H chains were also used in these analyses, but only two types of VH3 H chains were detected in the anti-Hib PS antibodies. These VH3 H chains are structurally related to VH genes that are preferentially rearranged in the early human repertoire. The implications of the restricted use of these VH regions in antibacterial antibodies is discussed.
Methods
Collection ofdonor sera. All volunteers were healthy Caucasian adults between 25 and 42 yr old without history of rheumatoid arthritis or other significant medical ailments, recurrent or recent infections, or hematologic abnormalities. Serum samples were obtained immediately before and after subcutaneous immunization with 40 tg of purified Hib PS vaccine (prepared by Dr. Porter Anderson, University ofRochester, Rochester, NY). Postimmunization specimens were drawn 1-2 mo later. Subjects were selected if anti-Hib PS antibody levels showed twofold or greater increases after vaccination. Samples were stored at -20'C until used, and aliquoted to avoid frequent freeze-thaws.
Synthetic peptides. Peptides were synthesized by R. Houghten using a modified solid phase technique (15) . Sequences were selected from immunodominant portions of Ig H and L chains, and were used to generate antisera (16) . The peptide sequences for the first FR region that are specific for the VK (13) and VH gene families (12, 14) have previously been described. In addition, a reagent was made that identifies the first FR sequence ofthe VH3-related 20P1/9-1 gene, designated VH3-FRla, that differs by a single amino acid residue from the VH3 prototype sequence, VH3-FRI (12, 17) . Antisera were also generated to portions ofthe second HV regions of all reported VH genes isolated from a 130-d fetal liver cDNA library. This highly restricted VH repertoire had 14 independent rearrangements that were derived from only 9 distinct VH germline genes (18) . In a previous report we described antipeptide antibodies to the homologous portion of genes from the VH4 family and VH6 family that are expressed in this fetal repertoire ( 14) . For this study we created additioifal second HV-specific reagents for the two VH 1 and four VH3 distinct sequences from this library. The peptides derived from the VH3 genes in this collection were designated VH3-HV2a, VH3-HV2b, VH3-HV2c, and VH3-HV2d. Also, a diagnostic portion of the third FR of one of the VH3 genes, 20P1/9-1, was also used to make an antipeptide antibody, and was designated anti-VH3-FR3a. The L chains in anti-Hib PS antibodies have been reported to have V region sequences homologous with a VK2 gene, A2 (1 1). Therefore, a peptide with the sequence EVSNRFSGVPDRGC was also made with a second HV region sequence taken from the A2 gene, and designated VK2-HV2a. Sequences of the VH3 genes and their source are compiled in Table I Generation ofantipeptide antibodies. Synthetic peptides were conjugated at their carboxy-terminal cysteine to the carrier, keyhole limpet hemocyanin, by using m-maleimido-benzoyl-N-hydroxysuccimide ester (19) . For the generation ofantipeptide sera, 4-6 wk-old female New Zealand white rabbits were immunized at 2-wk intervals with the peptide conjugate. The initial injections contained 0.5 mg ofpeptide equivalent in an emulsion with Freund's complete adjuvant, and the subsequent injections used 0.2 mg ofpeptide equivalent in incomplete adjuvant. Rabbits were bled 1 wk after the third immunization, and assayed for reactivity with peptides, as previously described (13) . Sera were stored at -20°C until used.
Immunoblot reactivity of antipeptide antibodies. To demonstrate the binding specificity of the peptide-induced reagents, Western immunoblot analyses were performed with Ig proteins of known and unknown primary amino acid sequence. Briefly, the H and L chains ofIgs were electrophoretically separated in 10% polyacrylamide gels containing 0.1% SDS, after boiling for 2 min in reducing buffer with 4% 2-mercaptoethanol. Before electrotransfer, immobilon P membrane (Millipore Corp., Bedford, MA) was wet in methanol, then equilibrated with transfer buffer. After transfer, nonspecific binding sites were quenched by incubation with borate buffered saline, pH 8.2 (BBS) containing 1% powdered milk (PM). The blotted membranes were then reacted for exactly 1 h with an antipeptide serum diluted 1:200 with 1% PM-BBS, on a rocking platform. After washing with Tween 20 0.05%-BBS (vol/ vol), membranes were incubated with 125I-protein A in 1% PM-BBS (sp act 0.1 MCi/ml) (ICN Radiochemicals Inc., Irvine, CA). After washing, the membranes were dried and exposed to Kodak XAR-5 film at -700C for 4 and 16 h. To document that replicate blots had equivalent Ig, after use they were reprobed by first rewetting with methanol, then equilibrated in 0.2 M glycine-HCI, pH 2.5. Stripping was aided by two cycles of 45-min incubation in an Autoblot apparatus (Bellco Biotechnology, Vineland, NJ) at 70'C. Blots were then rinsed with distilled water, and neutralized with 1% PM-BBS. To document stripping blots were next incubated with "I-protein A, and 24-h autoradiograms exposed. After final probing, blots were retested with antisera to constant region sequences to document that membranes had retained Ig protein.
Immunoblot reactivity ofantipeptides directed at K, X,MA, a, 'y immunoglobulin chain constant regions, and V region first FR region directed, VH and VK family specific reagents have previously been described (12, 13, 20, 21) .
Immunoprecipitation ofanti-Hib PS antibodies. A modification of the technique first described by Heidelbergerwas used to purify precipitating antibodies against the Hib PS (22). Serum samples from normal donors were first filtered through glass wool, placed in 1.5-ml tubes, and then spun for 40 min at 16K relative centrifugal force (RCF) at 4VC. Samples were then placed in clean tubes, and centrifugation repeated. Next, I ml of each plasma sample was placed in a clean tube and 2Mg of purified Hib PS was added, with incubation on a rotator at 370C for 1 h, then overnight at 4VC. Samples were then centrifuged for 10 min at 40C at 5K RCF. Supernatants were removed, then pellets were washed once in 0.2% BSA in PBS, pH 7.2 with 0.05% Tween 20, and respun. This procedure was repeated four additional times with PBS-Tween 20 0.05%. Afterwards pellets were resuspended in 2% SDS in 8 M urea. Laemmli reducing buffer was then added, before heating and electrophoretic separation ofIg chains in SDS-polyacrylamide gels. Antibodies from 1 ml of clarified serum were used for two replicate immunoblots. All studies were performed at least three times to ensure reproducibility.
Anti-Hib polysaccharide assay. Total antibody to Hib PS was measured using a radioactive '251-labeled antigen, as previously described (3) . Antibody concentrations were determined from a standard reference curve using dilutions of the U. S. Office of Biologics serum reference pool. Before and after precipitation ofantibodies for immunoblot analyses, serum samples were assayed for anti-Hib PS antibody content.
Results
Characterization ofanti-peptide antibodies. After three immunizations with peptide conjugates, all rabbits produced high titer antisera (> 1: 10,000) when tested by direct binding ELISA (data not shown). Immunoblot reactivity of antisera was next tested against Ig of known and unknown sequence.
We have previously demonstrated that the anti-VH3-FR1 reagent identifies only VH3-derived proteins. VH3 H chains are not identified by the reagents derived from other V gene families (12, 14) . In Fig, 1 
Immunoblot reactivity 
Immunoblot reactivity
Anti-VH3-FR3a
Amino acid sequences were taken from reported VH3 proteins or deduced from cDNA sequences. Dashes represent an identical amino acid residue. The VH3-FRI sequence is encoded by most VH3 genes, while the VH3-FRla has only been described in the 9-1 and M26 clones. Germline encoding sequences are *, others are from fetal repertoires. The VH3-HV2a, and VH3-FR3a sequences were deduced from the 20P1, M26, and 9-1 gene. The VH3-HV2b and VH3-HV2c are derived from the VH26 and Humhv3005 germline genes, respectively. The 4B4 H chain is encoded by the germline 9-1 sequence. The KIM4.6 H chain is encoded by the germline Humhv3005 sequence. The 18/2 H chain is encoded by the germline VH26 gene. RIV and LAY are IgM rheumatoid factors with unknown germline origin. To improve binding fine specificity, immunoblot reactivity of immobilized H chains was tested after preincubation of a peptide at 1 ig/ml with certain antisera. Blots are displayed in Fig. 1 . press the exact coding regions of the 30P1, 20P1, and 56P1
genes from the fetal repertoire, respectively (23) (24) (25) . To improve fine binding specificity, the same peptide preincubation technique was also used in immunoblot studies ofthe serologic reagents directed against second HV region sequences from VH3 genes. The VH3-HV2b sequence was derived from the related antipeptide antibodies.
VH3 gene, 30P1, that has an identical encoding region with the A ofpurified human Ig under VH26 germline gene. In Fig. 1 Fig. 2 , at left are displayed the reactivities of replicate blots with reagents specific for the VH families. Corroborating the recent report by Scott and co-workers (10), all 10 donors had major populations of anti-Hib PS antibodies which derived from the VH3 family. The H chains of anti-Hib PS antibodies were not identified by reagents specific for the minor VH families, VH2, VH5, and VH6 (not shown). However, anti-Hib PS antibodies from four individuals (CS, DT, NF, and DF) were also identified by the VH1 family-specific reagent (anti-VH 1-FR 1). The VH 1-derived antibodies induced in CS and DF were predominantly IgG isotype. A subset of the induced anti-Hib PS antibodies from an overlapping set of three individuals (SS, DT, and PT) were also derived from the VH4 family (anti-VH4-FR 1). In these panels, subsets of the unfractionated polyclonal IgG were also detected by the VH DT, and PT) were identified. These same four individuals (AW, CA, DT, and PT) had significant responses that were also identified by the anti-VH3-FR3a antibody, that was taken from the third FR sequence of 20P1. While FR sequences may be shared by different members of the same V gene family, the concurrent expression of HV sequences suggests that H chains structurally related to the 20P1 gene are commonly used in antibodies to Hib PS. Similar to the reactivity ofthe monoclonal IgG Fitz, the anti-Hib PS antibodies of DT and CA were each identified by two of the three reagents specific for the products of the 20P1 gene, which may suggest that they are either derived from different genic variants of 20P1 or have undergone somatic mutations.
In Fig. 2 , at right in the fourth panel, preincubation of the anti-VH3-FR I reagent did not alter the reactivity of this antibody with the anti-Hib PS antibodies. At bottom right, after preincubation with a peptide related to the immunizing peptide, the antibody specific for the second HV region ofthe 30P1 gene product, anti-VH3-HV2b, reacted with H chains of IgM, IgA, and IgG isotypes in five individuals (CA, CS, DT, NF, and PT), and also reacted with IgM and IgA antibodies from the five other individuals. Taken together, these reactivities are consistent with identification of the anti-Hib PS responses by certain VH3 family specific reagents. However, the anti-Hib PS antibodies were recognized neither by the serologic reagents against the HV region sequences of other VH3 gene, 56P1 and 38P1, nor to any ofthe other VH families in the fetal repertoire (data not shown). The reactivities ofthe antipeptide reagents to VH determinants are compiled in Table II . When compared to monoclonal Ig, the 20P1 and 30P 1-associated markers appear to be nonrandomly expressed in anti-Hib PS antibodies (twotailed Fischer exact test, P = 0.00042 and < 0.0001, respectively). These data suggest that immunization with the Hib PS nonstochastically induces dominant clones of VH3 antibodies that are structurally related to the products of the 20P1 and 30P1 genes.
To document that VH restriction was due to detection of antigen-specific responses, control precipitation studies were performed. When Sepharose beads were used, the V region distribution of the precipitated Ig was identical to unfractionated serum Ig (data not shown). In contrast, after immunization of 14 normal subjects with pneumococcal vaccine, the precipitates with the pneumococcal PS type 14 immunogen had equivalent subsets of Ig from two VH families in seven samples, while the remainder had antibodies from three VH families (Silverman, G. J., manuscript in preparation).
Analysis of VL diversity in circulating anti-Hib PS antibodies. Previous immunochemical analyses have documented that anti-Hib PS responses are dominated by VK-derived L chains (30) , and over 1/3 of patients have responses with > 90% kappa L chain restriction (31) . Illustrated in Fig. 3 and Table II , all 10 subjects were found to have a major induction ofVK-derived L chains. Only three individuals (AW, CS, and DF) had significant populations of X-derived L chains, and five additional subjects had minor X L chain populations. All 10 individuals also had induced responses that included VK2-derived L chains, of which 6 (CA, CS, DT, NF, PT, and DF) were also identified by the anti-VK2-HV2a reagent that identifies the products ofthe A2 gene. Compared to the panel ofmonoclonal Ig, the occurrence ofA2-linked L chains in anti-Hib PS antibodies appears to be nonrandom (P < 0.0001).
All individuals had a population ofthe anti-Hib PS antibodies with VK3-derived L chains, and seven individuals also had a minor subset of VK 1-derived antibodies. None of the anti-Hib PS responses reacted with the VK4 gene family specific reagent (not shown) (data compiled in Table II ). Ofnote, the patient SS had a significant population of VK3-derived antibodies before immunization, but immunization predominantly induced VK 1 Variable region diversity determined by immunoblot reactivity. The VK and VH families were determined with antipeptide antibodies to first FR determinants. The reactivity of anti-VH3-HV2a and anti-VH3-HV2b were determined after preincubation with a related synthetic peptide, to improve fine binding specificity. Reactivity of antisera to second HV and a third FR region sequences are displayed below the gene from which they derive. In each blot, after adjustment for total Ig detected by constant region specific reagents relative band intensity indicated +, ++, +++, ++++. (-) indicates not detected, and the limits of detection were <50 ng. H chains were not recognized by VH2, VH5, or VH6 family specific reagents (not shown). and VK2 antibodies. As previously described, this individual had VH4-derived anti-Hib PS antibodies, but immunization induced the appearance ofVH3 antibodies, which may suggest that not all cross-reacting B cell clones are stimulated by Hib PS immunization.
Discussion
Our study documents the restricted VH diversity in circulating antibodies induced by immunization with Haemophilus influenzae capsular polysaccharide. Based on studies with antipeptide antibodies that recognize diagnostic FR and HV region determinants, the anti-Hib PS antibodies from unrelated individuals preferentially express VH3 H chains. Although reagents specific for four types of VH3 H chains were also employed, these antibodies use only two of these types of H chains. Minor populations of VH 1 and VH4 antibodies to the Hib PS are expressed by some individuals, but the products of the VH2, VHS, and VH6 gene families are not used. These direct analyses of human antibody repertoires demonstrate that the physiologic responses ofindividuals in an outbred population can all use similar VH regions. Moreover, the two types of VH3 regions are structurally related to known VH genes. Our findings suggest that Hib PS immunization causes a specific induction of oligoclonal B cell clones that express 20P1 and 30P 1-related V regions.
Previous reports have concentrated on VL expression in these antibodies. We confirm and extend the observation that the VL regions ofanti-Hib PS antibodies are structurally heterogeneous, as all individuals had L chains from at least three VL families. In general, VK3-and VK2-derived L chains dominated the responses ofall 10 subjects. In agreement with past reports, we found that six individuals had anti-Hib PS antibodies with L chains derived from the A2 gene (or a closely related gene). Significantly, because these circulating antibodies were isolated by precipitation with antigen, the VH and VL regions identified in these anti-Hib PS antibodies should be representative of physiologically important antibodies.
The serologic reagents used in these studies were shown to be highly sequence specific, and in one instance could detect single conservative amino acid differences. However, these immunoblot studies cannot assign the exact genes from which these antibodies originate. Due to the degeneracy ofthe nucleic acid code and the possibility that sequences with conservative amino acid replacements are also identified, several related genes could encode for the recognized V region sequence. Even so, having identified characteristic features of the dominant clones of anti-Hib PS antibodies, the isolation and sequence analysis of physiologically representative clones will be greatly simplified, and the contribution ofsomatic mutation andjunctional diversity can be assessed.
Past studies have described antipeptide antibodies that recognize primary sequences in immunoglobulin HV regions (21, 32, 33) , and we have also previously described antipeptide antibodies that are V-gene family specific (12, 14) . However, previously antipeptide reagents have been applied only to the study of monoclonal Ig from cell lines or lymphoproliferative disorders, and this was the first application to the survey of a physiologic humoral response. This approach allows for the simultaneous analysis of induced antibodies of all isotypes.
Our studies were designed to qualitatively analyze the diversity of V regions present in anti-Hib PS antibodies. Quantitations of antibody content were also performed to ensure that the precipitation method removed a significant proportion of the anti-Hib PS antibodies. These determinations of anti-Hib PS content were also in accordance with relative band intensities within an immunoblot. It is unlikely that major antibody subpopulations were undetected. Extensive experience has documented that these antipeptide reagents can identify the V gene family origins of > 95% of monoclonal Ig from cell lines and lymphoproliferative syndromes ( [12] , unpublished observations). Moreover, if prolonged autoradiographic exposures are used, this method can detect minor subsets of polyclonal populations that represent < 0.5% of a band of 5 Ag (20) .
The human VH locus has been estimated to contain from 50 to 200 gene segments (17) . To date, six VH families have been described based on cross-hybridization and > 80% nucleic acid sequence homology within a family, and less than 70% homology between families. The VH3 family has the greatest genetic complexity. Restriction fragment analyses with full-length genes detect 25-30 VH distinct bands, that represent an estimated 50-100 members, with perhaps 30-40% pseudogenes (34, 35) . However, the extent of polymorphism is unknown, and the determination of whether minor sequence differences represents allelic differences or distinct genes is an area of active investigation (36) (37) (38) (39) (40) (41) (42) (43) . The products ofseveral genes related to 30P1 may be recognized by the anti-VH3-HV2b reagent. Of the nine distinct VH genes isolated in the first reported fetal repertoire, the VH3-HV2b sequence is present in both the 30P1 and the 60P2/63P1 clones (18) . The 30P1 clone and the VH26 germline gene are identical, and they are > 99% homologous with a related germline gene, J00236 (44) . To provide an estimate ofcomplexity of 30P1/VH26 related genes, Southern analysis was performed on genomic digests, and only five to seven bands were detected by hybridization at high stringency with a 5' VH26 flanking probe, or one to five bands when probed with oligonucleotides with sequences that overlap the VH3-HV2b region (36, 37) . The 30P1/VH26 and related genes have been shown to encode polyreactive antibodies with a variety of autoreactivities including anticardiololipin, antiplatelet membrane, insulin, vimentin, thyroglobulin, Fc, and anti-DNA (23, 44, 45) . The 18/2 IgM hybridoma was made from the peripheral cells of a leprosy patient, and it is directly encoded by the germline VH26 gene (23) . This antibody has binding capacity for both double stranded DNA and the Klebsiella capsular polysaccharide, K30, and we have used it as a positive control for 30P1/ VH26 encoded proteins. These antibodies also often bear the H chain associated 16/6 idiotype that is increased in the circulation of both lupus patients with active disease, and patients with systemic Klebsiella infection (46, 47) . Therefore, genes in the 30P1/VH26 subfamily are likely to be important in a variety of pathologic as well as physiologic responses.
Kabat and others have hypothesized that phosphodiester groups with a given spacial separation may constitute a crossreacting, immunodominant determinant present in DNA, phospholipids, and certain bacterial PS (48, 49) . Perhaps this common motif can be recognized by a conserved type of antigen binding site that can be encoded, in part by 30P1/VH26 related genes. In preliminary studies, the antibodies to several polyanionic pneumococcal PS also use related H chains (Silverman, G. J., unpublished observations). This model is consistent with the finding of structurally diverse L chains and restricted VH expression in anti-Hib PS antibodies, and would explain the high levels of VH26-associated idiotypes derived from anti-DNA antibodies that are often present in the circulation of patients with Klebsiella infections (50) .
Our study also found that a majority of subjects had circulating antibodies that are identified by reagents directed at sequences from the 20P1 gene from the fetal repertoire. By sequence comparison the 20P1 gene is a distant relative to other elements in the VH3 family, and it has been designated a separate subfamily (25) . Clones with sequences identical to 20P1 have been isolated from the germline, termed 9-1 (17) , from three fetal libraries of rearranged VH genes (51) , and from the 4B4 cell line (25) . In a sensitive gel hybridization method, only a single monomorphic band was identified when the genomic digests from 15 individuals were probed with an oligonucleotide with a sequence that overlaps the region used in our VH3-HV2a peptide (38) . Therefore, although not definitive, the cumulative data suggest that the' 20Pl/9-1 gene is highly conserved in outbred populations.
The IgM 4B4 is the direct expression of the germline 9-1 VH gene, and it was used as a control in our studies. It has the fine binding specificity for the Sm/RNP complex that is associated with human lupus, but this antibody also binds retrovirus gag protein (52) . Therefore, in addition to our characterization ofanti-Hib PS responses, antibodies derived from 20P1/9-1 related genes may also be expressed in response to other microbial pathogens.
The identification ofspecific VH3 region determinants that are conserved in human IgM, IgA, and IgG anti-Hib PS antibodies has significant genetic and structural implications. In addition to the evidence of restricted V gene usage, the retention ofhypervariable region sequences in IgA and IgG antibodies may suggest that antigenic selection has not systematically altered these recognition sites. Hib PS immunization may select B cell clones that express these VH genes either, because these germline genes express optimal antigen binding capacity, or due to regulation at the level of V gene rearrangements or B cell clonal expansion.
Our study of anti-Hib PS antibodies parallels recent findings concerning the human antibodies to the Ii system of related oligosaccharide determinants on membrane glycoconjugates ofautologous red blood cells. Monoclonal anti-I and antii autoantibodies from lymphoproliferative diseases are identified by both a VH4 family specific and a VH4 second HV region directed antipeptide reagent (21, 53) . More recently, anti-I and anti-i autoantibodies from lymphoblastoid cell lines were shown to be encoded by a single germline VH4 gene with little or no somatic point mutations, but can be associated with diverse L chains (53a). Presumably, these VH4 encoded autoantibodies have binding sites that are distinct from those of VH3 anti-Hib PS antibodies, which is reflective ofthe structural dissimilarity ofthese two carbohydrate targets, i.e., the Ii determinants are present on neutral oligosaccharides, while the Hib PS expresses a simple anionic polymeric structure ofribosylribitol phosphate.
In murine strains, high levels ofinduced antibodies to bacterial dextran requires expression of certain VH alleles (54, 55) , which may only be inducible after a defined point in development (54) . In humans, the anergy of infants to purified Hib PS can often be circumvented ifthe Hib antigen is conjugated to a protein carrier (56) . These antibody responses have been shown to share the idiotype expressed on anti-Hib PS antibodies in adults induced by purified Hib PS (9), but otherwise it is unknown whether these groups produce antibodies with the same V region biases. By application of our immunoblot technique we will be able to extend these studies to comparisons of the structural diversity of the anti-Hib PS antibodies that are induced during different stages of development by various Hib PS vaccine formulations.
A study has recently shown that immunization of certain Native American infants with a Hib PS conjugate vaccine induced only limited responses that were ineffective in protecting from Hib infection (5). The mechanism for this form ofnonresponse to Hib PS immunization is unknown. However, twin studies have documented that high responder status to many pneumococcal PS and to Hib PS is less dependent on environmental factors than on genetic factors (57) . In our study, all of the adult Caucasian subjects were shown to have responses that were dominated by structurally homogeneous VH regions. Therefore, this study presents a testable hypothesis. After confirmation that 20P1/9-1 and 30P1/VH26 related genes encode for anti-Hib PS antibodies, VH gene-specific probes can be designed for restriction fragment analysis. Genomic DNA can then be studied to determine whether nonresponders have VH gene locus deletions or absent VH genes, compared to high responders. This approach may indicate which exact alleles (or genes) are necessary for optimal anti-Hib PS response. Future investigations will also provide evidence of whether rearrangement of these genes is the structural basis for the postulated developmentally staged acquisition ofimportant antigen binding activities. Due to the simple epitopic structure of carbohydrates and the presumed limited role of somatic diversification in these antibody responses, it is apparent that the study of anticarbohydrate responses will reveal much about the forces that mold the preimmune repertoire, and the mechanism by which antigenic selection results in restricted V gene recruitment.
